Indian Pediatrics

, Volume 56, Issue 11, pp 929–932 | Cite as

Correlation of Dickkopf-1 with Inflammation in Crohn Disease

  • Mi Jin KimEmail author
  • Yon Ho Choe
Research Paper



To explore the potential roles of Dickkopf-1 (DKK-1) and β-catenin in Crohn disease, and to evaluate the effects of a tumor necrosis factor (TNF)-α inhibitor on Wnt signaling in patients with the disease.


We enrolled 21 patients who received infliximab treatment for one year and achieved clinical remission during the treatment period. Disease activity was graded according to the Pediatric Crohn’s Disease Activity Index (PCDAI). Peripheral blood and colonic mucosal specimens were collected from all patients with Crohn disease and from 14 healthy controls. DKK-1 levels in serum were detected by enzyme-linked immunosorbent assay (ELISA). Total RNA for DKK-1 and β-catenin from the frozen colonic tissue were obtained via real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR). Serum C-reactive protein (CRP) levels, erythrocyte sedimentation rates (ESR), and albumin were also measured in patients with Crohn disease before and after infliximab therapy.


The serum levels of DKK-1 were significantly higher in patients with Crohn disease than in healthy controls (P=0.003) and were decreased in those treated with infliximab (P=0.026). Serum DKK-1 level was correlated with levels of ESR (r=0.527, P=0.025), CRP (r=0.502, P=0.034), albumin (r=0.363, P=0.021) and PCDAI (r =0.462, P=0.054) in Crohn disease. DKK-1 mRNA expression in the colonic mucosa was higher in patients than in controls and decreased after infliximab treatment. β-catenin expression in the colonic mucosa was lower in patients than in controls and increased after infliximab treatment. However, the differences were not significant (P>>0.05).


DKK-1 might be an important mediator of the pathogenesis of Crohn disease, and changes in DKK-1 levels may serve as biomarkers of inflammation in these patients.


β-catenin Infliximab Pathogenesis Wnt signaling 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


Funding: This work was supported by the research fund of Chungnam National University.

Competing interests: None stated.


  1. 1.
    Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–24.CrossRefGoogle Scholar
  2. 2.
    Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427–34.CrossRefGoogle Scholar
  3. 3.
    Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med. 2000;51:289–98.CrossRefGoogle Scholar
  4. 4.
    Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781–810.CrossRefGoogle Scholar
  5. 5.
    Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127:469–80.CrossRefGoogle Scholar
  6. 6.
    Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004;5:691–701.CrossRefGoogle Scholar
  7. 7.
    Willert K, Jones KA. Wnt signaling: is the party in the nucleus? Genes Dev. 2006;20:1394–404.CrossRefGoogle Scholar
  8. 8.
    Fedi P, Bafico A, Nieto Soria A, Burgess WH, Miki T, Bottaro D P, et al. Isolation and biochemical characterization of the human Dkk-1 homologue, a novelinhibitor of mammalian Wnt signaling. J Biol Chem. 1999;274:19465–72.CrossRefGoogle Scholar
  9. 9.
    Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 1998;391:357–62.CrossRefGoogle Scholar
  10. 10.
    Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene. 2006;25:7469–81.CrossRefGoogle Scholar
  11. 11.
    de Lau W, Barker N, Clevers H. WNT signaling in the normal intestine and colorectal cancer. Front Biosci. 2007;12:471–91.CrossRefGoogle Scholar
  12. 12.
    Pinto D, Clevers H. Wnt control of stem cells and differentiation in the intestinal epithelium. Exp Cell Res. 2005;306:357–63.CrossRefGoogle Scholar
  13. 13.
    Inflammatory bowel disease in children and adolescents: Recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1–7.CrossRefGoogle Scholar
  14. 14.
    Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439–47.CrossRefGoogle Scholar
  15. 15.
    Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem. 2002;277:30998–1004.CrossRefGoogle Scholar
  16. 16.
    Miyaoka T, Seno H, Ishino H. Increased expression of Wnt-1 in schizophrenic brains. Schizophr Res. 1999;38:1–6.CrossRefGoogle Scholar
  17. 17.
    Jaworski T, Dewachter I, Lechat B, Gees M, Kremer A, Demedts D, et al. GSK-3alpha/beta kinases and amyloid production in vivo. Nature. 2011;480:E4–5; discussion E6.CrossRefGoogle Scholar
  18. 18.
    Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, et al. DKK1, anegative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene. 2004;23:8520–6.CrossRefGoogle Scholar
  19. 19.
    Gonzalez-Sancho JM, Aguilera O, Garcia JM, Pendas-Franco N, Pena C, Cal S, et al. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene. 2005;24:1098–103.CrossRefGoogle Scholar
  20. 20.
    Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007;13:156–63.CrossRefGoogle Scholar

Copyright information

© Indian Academy of Pediatrics 2019

Authors and Affiliations

  1. 1.Department of Pediatrics, Samsung Medical CenterSungkyunkwan University School of MedicineSeoulKorea

Personalised recommendations